rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke

Overview

The study will enroll 5 individuals post-stroke to examine the feasibility and efficacy of a high frequency repetitive transcranial magnetic stimulation (rTMS) combined with body weight supported treadmill training.

Full Title of Study: “High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Combined With Body Weight Supported Treadmill Training (BWSTT) After Stroke: A Pilot Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: November 26, 2018

Detailed Description

The purpose of this pilot study is to examine the feasibility and efficacy of 5Hz repetitive transcranial magnetic stimulation (rTMS) applied to bilateral motor areas as an adjuvant intervention to task-specific body weight supported treadmill training (BWSTT) in individuals with subacute stroke. Five individuals with a diagnosis of subacute stroke will be recruited and assigned to either high frequency or sham rTMS group.Both groups will receive a comprehensive assessment of their motor function, gait performance and neurophysiological function before the training. Both groups will then go through a 10 week (24 sessions) of gait training with body weight supported treadmill. For the high frequency rTMS group, they will receive 5 Hz rTMS applied to bilateral motor areas prior to each gait training session. For the sham rTMS group, they will receive a sham stimulation prior to the gait training sessions. All participants will receive another comprehensive assessment after the training concludes. The assessor will be blinded to the intervention.

Interventions

  • Device: High Frequency rTMS
    • Participants in the intervention group will receive 1200 stimuli at the intensity of 90% of resting motor threshold via an air-filmed coil placed on the vertex. The stimulation will be delivered across 24 sessions (in 10 weeks). Right after each session, participants will receive a 45-minute structured body weight supported treadmill training.
  • Device: Sham rTMS
    • Participants in the sham group will receive the same duration of stimulation via a sham coil placed on the vertex.Right after each session, participants will receive a 45-minute structured body weight supported treadmill training.

Arms, Groups and Cohorts

  • Experimental: High Frequency rTMS
    • The High Frequency rTMS group will receive real repetitive transcranial magnetic stimulation (rTMS) in 5Hz at 90% of resting motor threshold delivered to the bilateral motor areas via a figure of 8 air-filmed coil. The stimulation is structured as 24 10-second trains with a inter-train interval of 30 second.
  • Sham Comparator: Sham rTMS
    • The Sham rTMS group will receive the same protocol but delivered via a sham coil which generates the same auditory and cutaneous feedback as the real stimulation. However, there will be no active stimulation.

Clinical Trial Outcome Measures

Primary Measures

  • Change in Walking Speed
    • Time Frame: 10 weeks
    • Participant’s regular and fast walking speeds (in m/s) will be measured using GaitRite. A faster walking speed indicates a better gait performance.

Secondary Measures

  • Change in Quality of Life
    • Time Frame: 10 weeks
    • Quality of life will be measure using Stroke Impact Scale (SIS). The SIS is a paper and pencil questionnaire consisting 59 items grouped into 8 domains. Each item is rated on a 5-point Likert scale; a higher item score indicates a lower level of difficulty experienced with the item. Item scores are averaged and transformed into domain scores ranging from 0 to 100. A higher domain score indicates a lower level of difficulty. The SIS is well-validated in stroke.
  • Change in Motor Function
    • Time Frame: 10 weeks
    • Motor function will be quantified using Fugl-Meyer Motor Assessment. The Fugl-Meyer Assessment is well-validated in stroke and has a total score ranging from 0 to 100. A higher total score suggests a better level of motor function.
  • Change in Cortical Excitability
    • Time Frame: 10 weeks
    • Cortical excitability will be measured using single pulse transcranial magnetic stimulation. Excitability will be quantified using motor evoked potential amplitude (in mV). A higher motor evoked potential amplitude indicates a greater level of excitability.
  • Change in Walking Endurance
    • Time Frame: 10 weeks
    • Walking endurance will be measured using Six Minute Walk Test and measured in meters. A higher score in the 6 minute walk test (in meters) indicates a better walking endurance.

Participating in This Clinical Trial

Inclusion Criteria

1. 18-80 years old 2. < 2 months post stroke at the time of enrollment 3. first time stroke: 4. able to walk > 25 feet with or without assistive device and with no more than moderate assistance: 5. able to follow 1-step commands 6. able to communicate verbally Exclusion Criteria:

1. severe medical problems (e.g. recent cardiac infarct, heart failure, cancer) 2. presence of conditions that could affect gait training (e.g. amputation, severe arthritis) 3. bilateral stroke 4. non-ambulatory prior to stroke 5. BMI > 40 6. any contraindications to TMS (e.g. history of seizure, cardiac pacemaker, metal or magnetic implants) 7. pregnant or potentially to be pregnant

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Texas Woman’s University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Hui Ting Goh, Assistant Professor – Texas Woman’s University
  • Overall Official(s)
    • Hui-Ting Goh, Principal Investigator, Texas Woman’s University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.